Academic researchers interested in the commercialization of regenerative-medicine therapies stand to benefit from an understanding of the overall commercialization process. This Review covers, with specific examples, the salient commercialization aspects of protecting intellectual property, navigating regulatory pathways and obtaining funding.
- Takumi Takahashi
- Ryan P. Donahue
- Kyriacos A. Athanasiou